UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:14 TC[Scopus]:20  IF:9.1/9.0 | Submit date:2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in parkinson's disease Journal article
Zhao, Yuying, Xiong, Sha, Liu, Piaoxue, Liu, Wei, Wang, Qun, Liu, Yao, Tan, Hanxu, Chen, Xiaojia, Shi, Xuguang, Wang, Qi, Chen, Tongkai. Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in parkinson's disease[J]. International Journal of Nanomedicine, 2020, 15, 10453-10467.
Authors:  Zhao, Yuying;  Xiong, Sha;  Liu, Piaoxue;  Liu, Wei;  Wang, Qun; et al.
Favorite | TC[WOS]:56 TC[Scopus]:69 | Submit date:2021/03/02
Blood–brain Barrier  Drug Delivery System  Endocytosis  Pd Treatment  Zebrafish